EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Functional DPP4 Receptor Is an Indispensable Factor Mediating the Immune Performance of Mucosal Vaccines for Middle East Respiratory Syndrome

Zhenshan Wang iD, Xiaojun Hu, Shen Wang, Hongyu Sun, Yongkun Zhao, Na Feng, Tiecheng Wang, Guixue Hu, Jianzhong Wang iD, Xianzhu Xia iD, Feihu Yan iD

Transboundary and Emerging Diseases · 2025

DOI: 10.1155/tbed/2303502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2025. Verfasst von Zhenshan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jilin Agricultural University, Changchun 130022, China. Hauptthemen laut MEDLINE: Middle East Respiratory Syndrome Coronavirus, Dipeptidyl Peptidase 4, Viral Vaccines, Coronavirus Infections. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosal vaccines are powerful tools for combatting emerging infectious diseases, particularly mucosal‐associated pathogens. However, one of the main bottlenecks in developing mucosal vaccines is the lack of accurate animal models. In this study, a vesicular stomatitis virus (VSV)‐vectored Middle East respiratory syndrome coronavirus (MERS‐CoV) mucosal vaccine was designed for investigations. Compared with the VSV backbone, rVSVΔG‐MERS‐S exhibited altered cellular tropism, as determined by MERS‐S. In wild‐type (WT) C57BL‐6J mice and hamsters, the nasal spray of rVSVΔG‐MERS‐S was poorly immunogenic. In contrast, rVSVΔG‐MERS‐S was highly immunogenic in transgenic mice (hDPP4 mice) and hDPP4‐transduced hamsters harboring the functional MERS‐CoV receptor. Compared with those of WT C57BL‐6J mice, the nasal spray of rVSVΔG‐MERS‐S resulted in effective antigen‐presenting cell (APC) priming, Tfh‐GcB‐plasma cell (pC) proliferation, and robust humoral and cellular responses, together with the activation of antiviral signaling pathways in hDPP4 mice. Similarly, rVSVΔG‐MERS‐S was highly immunogenic in alpacas and rhesus monkeys, which are naturally susceptible to MERS‐CoV and harbor the effective DPP4 receptor. The alignment of hDPP4 receptors in these animals revealed that L294, I295, and R336 in DPP4 are key residues contributing to differences in sensitivity across species. Consistently, a high binding affinity was observed between human, alpacas, and rhesus monkey DPP4 receptors and MERS‐CoV receptor binding domains (RBDs) compared with that of mice and hamster. Overall, this proof‐of‐concept study not only guides the selection of appropriate animal models for the evaluation of mucosal vaccines of MERS but also provides evidence that functional receptors DPP4 in animal models are prerequisites for the immune performance of the MERS mucosal vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Middle East Respiratory Syndrome CoronavirusDipeptidyl Peptidase 4Viral VaccinesCoronavirus InfectionsAnimalsMiceMice, Inbred C57BLCricetinaeMice, TransgenicHumansImmunity, Mucosal

Stichwörter der Autor:innen

Middle East respiratory syndromeanimal modelbinding affinitydipeptidyl peptidase-4mucosal vaccines

Substanzen

Dipeptidyl Peptidase 4Viral Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Jilin Agricultural University, Changchun 130022, China.
  • Changchun Veterinary Research Institute, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Chinese Academy of Agricultural Sciences, Changchun 130022…
  • Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.

ORCID-Profile: Zhenshan Wang, Jianzhong Wang, Xianzhu Xia, Feihu Yan

Zitieren

APA

Wang, Z., Hu, X., Wang, S., Sun, H., Zhao, Y., Feng, N., Wang, T., Hu, G., Wang, J., Xia, X., & Yan, F. (2025). The Functional DPP4 Receptor Is an Indispensable Factor Mediating the Immune Performance of Mucosal Vaccines for Middle East Respiratory Syndrome. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/2303502

Vancouver

Wang Z, Hu X, Wang S, Sun H, Zhao Y, Feng N, et al. The Functional DPP4 Receptor Is an Indispensable Factor Mediating the Immune Performance of Mucosal Vaccines for Middle East Respiratory Syndrome. Transboundary and Emerging Diseases. 2025. doi:10.1155/tbed/2303502

BibTeX
@article{Wang2025,
  author = {Wang, Zhenshan and Hu, Xiaojun and Wang, Shen and Sun, Hongyu and Zhao, Yongkun and Feng, Na and Wang, Tiecheng and Hu, Guixue and Wang, Jianzhong and Xia, Xianzhu and Yan, Feihu},
  title = {The Functional DPP4 Receptor Is an Indispensable Factor Mediating the Immune Performance of Mucosal Vaccines for Middle East Respiratory Syndrome},
  journal = {Transboundary and Emerging Diseases},
  year = {2025},
  doi = {10.1155/tbed/2303502}
}
Kostenlos starten →